Offer - Urjas Oil for just ₹ 1 X
Regrace 1 Mg Tablet is a prescription drug, available for use as Tablet. Schizophrenia are some of its major therapeutic uses. The alternative uses of Regrace 1 Mg Tablet have also been explained below.
The correct dosage of Regrace 1 Mg Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
While these are the most often observed Regrace 1 Mg Tablet side effects, there are can be others also. These have been listed below. Such side effects of Regrace 1 Mg Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Regrace 1 Mg Tablet's effect during pregnancy is Moderate and Severe while nursing. It is important to know if Regrace 1 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Regrace 1 Mg Tablet related warnings section.
Regrace 1 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Regrace 1 Mg Tablet in conditions like Tardive Dyskinesia, Kidney Disease, Liver Disease. Other conditions have been mentioned below in the Regrace 1 Mg Tablet contraindications section.
Additionally, Regrace 1 Mg Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Regrace 1 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Regrace 1 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Regrace 1 Mg Tablet safe for pregnant women?
Regrace can have harmful effects in pregnant women. If you experience any discomfort after using Regrace, then discontinue the use and take your doctor's advice.
Is the use of Regrace 1 Mg Tablet safe during breastfeeding?
Regrace may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Regrace 1 Mg Tablet on the Kidneys?
Regrace may have mild side effects on the kidneys.
What is the effect of Regrace 1 Mg Tablet on the Liver?
Side effects of Regrace rarely affect the liver.
What is the effect of Regrace 1 Mg Tablet on the Heart?
Regrace may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Regrace 1 Mg Tablet unless your doctor advises you to do so -
Is this Regrace 1 Mg Tablet habit forming or addictive?
Regrace 1 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Regrace 1 Mg Tablet, you should not drive or work on any heavy machine, as Regrace 1 Mg Tablet can make you drowsy.
Is it safe?
Yes, but consume Regrace 1 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Regrace 1 Mg Tablet can help with mental disorders.
Interaction between Food and Regrace 1 Mg Tablet
Regrace 1 Mg Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Regrace 1 Mg Tablet
Consuming Regrace 1 Mg Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Risperdal® (risperidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441-442
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1101-1103